Evidence map

TrialDiabetes care2008

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.

Vivian A Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

81 papers cite itlatest 60 shown

2008
2011
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 18458145